{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"ACADIA Pharmaceuticals Inc."},"Symbol":{"label":"Symbol","value":"ACAD"},"Address":{"label":"Address","value":"12830 EL CAMINO REAL SUITE 400, SAN DIEGO, California, 92130, United States"},"Phone":{"label":"Phone","value":"+1 858 558-2871"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology."},"CompanyUrl":{"label":"Company Url","value":"https://www.acadia-pharm.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Bob Mischler","title":"Senior VP-Strategy &amp; Technology Operations"},{"name":"Brendan Teehan","title":"Chief Operating Officer, EVP &amp; Head-Commercial"},{"name":"Douglas Williamson","title":"Executive VP, Head-Research &amp; Development"},{"name":"Ponni Subbiah","title":"Chief Medical Officer &amp; Senior Vice President"},{"name":"Stephen R. Davis","title":"Chief Executive Officer &amp; Director"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}